Human TFF2/SML1/SP ORF/cDNA clone-Lentivirus particle (NM_005423)
Cat. No.: vGMLP002301
Pre-made Human TFF2/SML1/SP Lentiviral expression plasmid for TFF2 lentivirus packaging, TFF2 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
TFF2/SML1 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
| Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
|---|---|---|---|
| vGMLP002301 | Human TFF2 Lentivirus particle | Pilot Grade | 1.0E+8TU |
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| Research Grade | 1.0E+8TU | ||
| 5.0E+8TU | |||
| 1.0E+9TU | |||
| GMP-like Grade | inquiry | ||
| GMP Grade | inquiry |
Product Description
| Catalog ID | vGMLP002301 |
| Gene Name | TFF2 |
| Accession Number | NM_005423 |
| Gene ID | 7032 |
| Species | Human |
| Product Type | Lentivirus particle (overexpression) |
| Insert Length | 390 bp |
| Gene Alias | SML1,SP |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGGGACGGCGAGACGCCCAGCTCCTGGCAGCGCTCCTCGTCCTGGGGCTATGTGCCCTGGCGGGGAGTGAGAAACCCTCCCCCTGCCAGTGCTCCAGGCTGAGCCCCCATAACAGGACGAACTGCGGCTTCCCTGGAATCACCAGTGACCAGTGTTTTGACAATGGATGCTGTTTCGACTCCAGTGTCACTGGGGTCCCCTGGTGTTTCCACCCCCTCCCAAAGCAAGAGTCGGATCAGTGCGTCATGGAGGTCTCAGACCGAAGAAACTGTGGCTACCCGGGCATCAGCCCCGAGGAATGCGCCTCTCGGAAGTGCTGCTTCTCCAACTTCATCTTTGAAGTGCCCTGGTGCTTCTTCCCGAAGTCTGTGGAAGACTGCCATTACTAA |
| ORF Protein Sequence | MGRRDAQLLAALLVLGLCALAGSEKPSPCQCSRLSPHNRTNCGFPGITSDQCFDNGCCFDSSVTGVPWCFHPLPKQESDQCVMEVSDRRNCGYPGISPEECASRKCCFSNFIFEVPWCFFPKSVEDCHY |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-SE1333-Ab | Anti-TFF2/ SML1/ SP functional antibody |
| Target Antigen | GM-Tg-g-SE1333-Ag | TFF2 protein |
| ORF Viral Vector | pGMLP002301 | Human TFF2 Lentivirus plasmid |
| ORF Viral Vector | vGMLP002301 | Human TFF2 Lentivirus particle |
Target information
| Target ID | GM-SE1333 |
| Target Name | TFF2 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
7032 |
| Gene ID |
100051351 (Equus caballus), 100170653 (Felis catus), 116592 (Rattus norvegicus), 21785 (Mus musculus) 403489 (Canis lupus familiaris), 616105 (Bos taurus), 7032 (Homo sapiens), 714550 (Macaca mulatta) |
| Gene Symbols & Synonyms | TFF2,Tff2,SP,mSP,SML1 |
| Target Alternative Names | SML1,SP,Spasmolysin,Spasmolytic polypeptide (SP),TFF2,Tff2,Trefoil factor 2,mSP |
| Uniprot Accession |
Q03403,Q03404,Q09030,Q863J2
Additional SwissProt Accessions: Q09030,Q03404,Q863J2,Q03403 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Diagnostics Biomarker |
| Disease | cancer |
| Disease from KEGG | |
| Gene Ensembl | ENSMUSG00000024028, ENSCAFG00845030490, ENSBTAG00000030814, ENSG00000160181, ENSMMUG00000064839 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


